SCHEMBL579902

SCHEMBL579902

CC(C)(C)C1(O)CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15187736 1.00 OPRM1 (0.35) OPRM1OPRD1OPRK1OPRL1ALDH1A1
Potassium SCHEMBL9297432 0.97 OPRM1 (0.34) OPRM1OPRD1OPRK1OPRL1ALDH1A1
SCHEMBL12971961 0.97 OPRM1 (0.36) OPRM1OPRD1OPRK1OPRL1
SCHEMBL1090888 0.90
SCHEMBL4729116 0.83
SCHEMBL595093 0.81 ALDH1A1 (0.33) ALDH1A1
SCHEMBL176374 0.81 ALDH1A1 (0.33) ALDH1A1
Acrylic Acid SCHEMBL7191461 0.80 LMNA (0.40) OPRM1OPRD1OPRK1OPRL1
Methacrylic Acid SCHEMBL28683569 0.80 SMN1; SMN2 (0.31) OPRM1OPRD1OPRK1OPRL1
SCHEMBL4674350 0.79 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1083 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717744-A1 USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE Bostik SA (FR) 2026-04-01 EP claimed
US-20260078213-A1 METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE ARKEMA FRANCE (FR) 2026-03-19 US claimed
EP-4504813-B1 SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION H K WENTWORTH LTD (GB) 2026-02-11 EP claimed
WO-2025229275-A1 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS BOSTIK SA (FR) 2025-11-06 WO claimed
WO-2025215194-A1 ENHANCED REMOVABILITY OF NAIL COATINGS USING ACIDIC COPOLYMERS FOR TRIGGERED REMOVAL WITH AQUEOUS BASED REMOVER ARKEMA FRANCE (FR) 2025-10-16 WO claimed
WO-2025215193-A1 ACIDIC OLIGOMERS USED IN DEINKING PROCESS ARKEMA FRANCE (FR) 2025-10-16 WO claimed
WO-2025215191-A1 CURABLE COMPOSITIONS COMPRISING AN ACIDIFIED ANHYDRIDE OLIGOMER USEFUL IN DEINKING PROCESSES ARKEMA FRANCE (FR) 2025-10-16 WO claimed
EP-4587497-A1 METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE ARKEMA FRANCE (FR) 2025-07-23 EP claimed
US-12351659-B2 Curable composition comprising a photoinitiator ARKEMA FRANCE (FR) 2025-07-08 US claimed
CN-119954644-A Method for producing succinic acid ester by maleic anhydride 上海师范大学 2025-05-09 CN claimed
US-20090269297-A1 MULTIPLE COMPONENT COMPOUND AND METHOD FOR NEUTRALIZING OFFENSIVE ODORS BELLE-AIRE FRAGRANCES, INC. 2009-10-29 US claimed
WO-2009131748-A1 MULTIPLE COMPONENT COMPOUND AND METHOD FOR NEUTRALIZING OFFENSIVE ODORS BELLE-AIRE FRAGRANCES, INC. (US) 2009-10-29 WO claimed
EP-1853214-A1 BACTERICIDAL FORMULATIONS Givaudan SA (CH) 2007-11-14 EP claimed
WO-2006053458-A1 BACTERICIDAL FORMULATIONS GIVAUDAN SA (CH) 2006-05-26 WO claimed
US-6818791-B2 Method for producing higher (meth)acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2004-11-16 US claimed
US-20040030179-A1 Method for producing (meth)acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2004-02-12 US claimed
US-20040024241-A1 Method for producing higher (meth)acrylic acid esters BASF AKTIENGESELLSCHAFT (DE) 2004-02-05 US claimed
EP-1345887-A1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF AKTIENGESELLSCHAFT (DE) 2003-09-24 EP claimed
WO-2002050015-A1 METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS BASF AKTIENGESELLSCHAFT (DE) 2002-06-27 WO claimed
EP-0755910-B1 Process for preparing 4-tert.-butylcyclohexanol SUMITOMO CHEMICAL CO (JP) 2001-10-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12351659-B2 Curable composition comprising a photoinitiator EED, CDH1, EPB41 OPRM1 4564/4885OPRD1 4302/4885OPRK1 4707/4885
US-20260078213-A1 METHOD FOR PREPARING AN AMINOSUCCINIC RESIN WITH A LOW AMINE VALUE SRM, JMJD6, MAT1A OPRM1 320/4885OPRD1 1062/4885OPRK1 911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.